Whipple's disease: Mechanisms;La maladie de Whipple: Mécanismes

Hepato-Gastro

Volumn 11, Issue 3, 2004, Pages 207-219

  Matuchansky, Claude ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2;

ACTINOBACTERIA; CYTOKINE PRODUCTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INTESTINE LIPODYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TROPHERYMA WHIPPELII;

EID: 2642513033     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tisues. Bull Johns Hopkins Hosp 1907; 18: 382-91.
2. Black-Schaffer B. The tinctorial demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol Med 1949; 72: 225-7.
3. Sieracki JC. Whipple's disease: observation on systemic involvement. Arch Pathol 1958; 66: 464-7.
4. Cohen AS, Schimmel EM, Holt PR, Isselbacher KJ. Ultrastructural abnormalities in Whipple's disease. Proc Soc Exp Biol Med 1960; 105: 411-4.
5. Yardley JH, Hendrix TR. Combined electron microscopy and light microscopy in Whipple's disease: demonstration of "bacillary bodies" in the intestine. Bull Johns Hopkins Hosp 1961; 109: 80-98.
6. Chears WC, Ashworth CT. Electron microscopy study of the intestinal mucosa in Whipple's disease: demonstration of encapsulated bacteria bodies in the lesion. Gastroenterology 1961; 41: 129-38.
7. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's disease-associated bacterium. Lancet 1991; 338: 474-5.
8. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992; 327: 293-301.
9. Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000; 342: 620-5.
10. Dumler JS, Baisden BL, Yardley JH, Raoult D. Immunodetection of Tropheryma whipplei in intestinal tissues from Dr Whipple's 1907 patient. N Engl J Med 2003; 348: 1411-2.
11. Liang Z, La Scola B, Raoult D. Monoclonal antibodies to immunodominant epitopes of Tropheryma whipplei. Clin Diagn Lab Immunol 2002; 9: 156-9.
12. Bentley SD, Maiwald M, Murphy LD, Pallen MJ, Yeats CA, Dover LG, et al. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet 2003; 361: 637-44.
13. Raoult D, Ogata H, Audic S, Robert C, Suhre K, Drancourt M, et al. Tropheryma whipplei Twist: A human pathogenic actinobacteria with reduced genome. Genome Res 2003; 13: 1800-9.
14. Marth T, Raoult D. Whipple's disease. Lancet 2003; 361: 239-46.
15. Dutly F, Altwegg M. Whipple's disease and "Tropheryma whippelii". Clin Microbiol Rev 2001; 14: 561-83.
16. Dobbins WO III. Whipple's disease. Springfield, Illinois: Charles C Thomas, 1987.
17. Durand DV, Lecomte C, Cathebras P, Rousset H, Godeau P. Whipple's disease: clinical review of 52 cases. Medicine 1997; 76: 170-84.
18. Von Herbay A, Otto HF, Stolte M, Borchard F, Kirchner T, Ditton HJ, Maiwald M. Epidemiology of Whipple's disease in Germany: analysis of 110 patients diagnosed in 1965-1995. Scand J Gastroenterol 1997; 32: 52-7.
19. Misbah SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption - new atypical features. Q J Med 1997; 90: 765-72.
20. Maizel H, Ruffin JM, Dobbins WO III. Whipple's disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine 1970; 49: 175-205.
21. Gross JB, Wollaeger EE, Sauer WG, Huizenga KA, Dahlin DC, Power MH. Whipple's disease: report of four cases, including two brothers, with observations on pathologic physiology, diagnosis and treatment. Gastroenterology 1959; 36: 65-93.
22. Dyckmann DD, Cuccherini BA, Fuss IJ, Blum LW, Woodward JE, Strober W. Whipple's disease in a father-daughter pair. Dig Dis Sci 1998; 44: 2542-4.
23. Feurle GE, Dörken B, Schöpf E, Lenhard V. HLA-B27 and defects in the T-cell system in Whipple's disease. Eur J Clin Invest 1979; 9: 385-9.
24. Schoedon G, Goldenberger D, Forrer R, Gunz A, Dutly F, Höchli M, et al. Deactivation of macrophages with interkeukin-4 is the key to the isolation of Tropheryma whippelii. J Infect Dis 1997; 176: 672-7.
25. Raoult D, La Scola B, Lecoq P, Lepidi H, Fournier PE. Culture and immunological detection of Tropheryma whipplei from the duodenum of a patient with Whipple's disease. JAMA 2001; 285: 1039-43.
26. Fenollar F, Birg ML, Gauduchon V, Raoult D. Culture of Tropheryma whipplei from human samples: a 3-year experience (1999-2002). J Clin Microbiol 2003; 41: 3816-22.
27. Masselot M, Boulos A, Maurin M, Rolain JM, Raoult D. Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm. Antimicrobial Agents Chemother 2003; 47: 1658-64.
28. Ghigo E, Capo C, Aurouze M, Tung CH, Gorvel JP, Raoult D, et al. Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. Infect Immun 2002; 70: 1501-6.
29. Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Int Med 1999; 159: 167-73.
30. Silva T, Macedo PM, Nunes JF. Ultrastructure of bacilli and bacillary origin of the macrophagic inclusions of Whipple's disease. J Gen Microbiol 1985; 131: 1001-13.
31. Baisden BL, Lepidi H, Raoult D, Yardley JH, Dumler S, Argani P. Diagnosis of Whipple's disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol 2002; 118: 742-8.
32. Stackebrandt E, Riney FA, Ward-Rainey NL. Proposal for a new hierarchic classification system. Actinobacteria classis nov. Int J Syst Bacteriol 1997; 47: 479-91.
33. Hinrikson HP, Dutly F, Altwegg M. Homogeneity of 16S-23S ribosomal intergenic spacer regions of Tropheryma whippelii in Swiss patients with Whipple's disease. J Clin Microbiol 1999; 37: 152-6.
34. Maiwald M, von Herbay A, Persing DH, Mitchell PS, Abdelmalek MF, Thorvilson JN, et al. Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple's disease. Ann Int Med 2001; 134: 115-9.
35. Ehrbar HU, Bauerfeind P, Dutly F, Koelz HR, Altwegg M. PCR-positive tests for Tropheryma whippelii in patients without Whipple's disease. Lancet 1999; 353: 2214.
36. Von Herbay A, Ditton HJ, Maiwald M. Diagnostic application of a polymerase choin reaction assay for the Whipple's disease bacterium to intestinal biopsies. Gastroenterology 1996; 110: 1735-43.
37. Fenollar F, Fournier PE, Raoult D, Gérolami R, Lepidi H, Poyart C. Quantitative detection of Tropheryma whipplei DNA by real-time PCR. J Clin Microbiol 2002; 40: 1119-20.
38. Moorthy S, Nolley G, Hermos JA. Whipple's disease with minimal intestinal involvement. Gut 1977; 18: 152-5.
39. O'Duffy JD, Griffing WL, Li CY, Abdelmalek MF, Persing DH. Whipple's arthritis: direct detection of Tropheryma whippelii in synovial fluid and tissue. Arthritis Rheum 1999; 42: 812-7.
40. Rickman LS, Freeman WR, Green WR, Feldman ST, Sullivan J, Russack V, et al. Uveitis caused by Tropheryma whippelii (Whipple's bacillus). N Engl J Med 1995; 332: 363-6.
41. Maibach RC, Dutly F, Altwegg M. Detection of Tropheryma whippelii DNA in feces by PCR using a target capture method. J Clin Microbiol 2002; 40: 2466-71.
42. Feurle GE, Volk B, Waldherr R. Cerebral Whipple's disease with negative jejunol histology. N Engl J Med 1979; 300: 907-8.
43. Street S, Donoghue HD, Neild GH. Tropheryma whippelii DNA in saliva of healthy people. Lancet 1999; 354: 1178-9.
44. Dutly F, Hinrikson HP, Seidel T, Morgenegg S, Altwegg M, Bauerfeind P. Tropheryma whippelii DNA in saliva of patients without Whipple's disease. Infection 2000; 28: 219-22.
45. Wendler D, Mendoza E, Schleiffer T. Tropheryma whippelii endocarditis confirmed by polymerase chain reaction. Eur Heart J 1995; 16: 424-5.
46. Raoult D, Lepidi H. Tropheryma whipplei circulating in blood monocytes. N Engl J Med 2001; 345: 548.
47. James TN. The protean nature of Whipple's disease includes multiorgan arteriopathy. Trans Am Clin Climatol Assoc 2001; 112: 196-214.
48. Alkan S, Beals TF, Schnitzer B. Primary diagnosis of Whipple's disease manifesting as lymphadenopathy. Am J Clin Pathol 2001; 116: 898-904.
49. Puechal X. Whipple disease and arthritis. Curr Opin Rheumatol 2001; 13: 74-9.
50. Muller C, Stain C, Burghuber O. Tropheryma whipplei in peripheral blood mononuclear cells and cells of pleural effusion. Lancet 1993; 341: 701.
51. Von Herbay A, Ditton HJ, Schuhmacher F, Maiwald M. Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology 1997; 113: 434-41.
52. Anderson A. Neurology of Whipple's disease. J Neurol Neurosurg Psychiatry 2000; 68: 2-5.
53. Schaffner A, Schneemann M. Whipple's disease: from enigma to genomics. Lancet 2003; 361: 632.
54. Lowsky R, Archer GL, Fyles G, Minden M, Curtis J, Messner H, et al. Diagnosis of Whipple's disease by molecular analysis of peripheral blood. N Engl J Med 1994; 331: 1343-6.
55. Fredricks DR, Relman DA. Localization of Tropheryma whippelii rRNA in tissues from patients with Whipple's disease. J Infect Dis 2001; 183: 1229-37.
56. The Wellcome Trust Sanger Institute. Tropheryma whippelii, 2002. htpp://www.sanger.ac.uk/Projects/T_whippelii/ (accessed Feb 11, 2003).
57. Casjens S. The diverse and dynamic structure of bacterial genomes. Annu Rev Genet 1998; 32: 339-77.
58. Renesto P, Crapoulet N, Ogata H, La Scola B, Vestris G, Claverie JM, et al. Genome-based design of a cell-free medium for Tropheryma whipplei. Lancet 2003; 362: 447-9.
59. Cannon WR. Whipple's disease, genomics, and drug therapy. Lancet 2003; 361: 1916.
60. Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A. Environmental occurrence of the Whipple' disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 1998; 64: 760-2.
61. Relman DA. Whipple's disease. In: MJ Blaser, PD Smith, JI Ravdin, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995: 919-36.
62. Ward DM, Weller R, Bateson MM. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature 1990; 345: 63-5.
63. La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MN, Raoult D. Description of Tropheryma whipplei gen nov, sp nov, the Whipple's disease bacillus. Int J Syst Evol Microbiol 2001; 51: 1471-9.
64. Hinrikson HP, Dutly F, Nair S, Altwegg M. Detection of three different types of "Tropheryma whippelii" directly from clinical specimens, single-strand conformation polymorphism (SSCP) analysis and type-specific PCR of their 16S-23S ribosomal intergenic spacer region. Int J Syst Bacteriol 1999; 4: 1701-6.
65. Fenollar F, Raoult D. Whipple's disease. Clin Diagn Lab Immunol 2001; 8: 1-8.
66. Swartz MN. Whipple's disease: past, present, and future. N Engl J Med 2000; 342: 648-50.
67. Ectors N, Geboes K, De Vos R. Whipple's disease: a histological, immunocytochemical and electronmicroscopic study of the immune response of the small intestinal mucosa. Histopathology 1992; 21: 1-12.
68. Marth T, Roux M, von Herbay A, Meuer SC, Feurle GE. Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin Immunol Immunopathol 1994; 72: 217-26.
69. Marth T, Neurath M, Cuccherini BA, Strober W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997; 113: 442-8.
70. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-27.
71. Ross GD, Vetvicka V. CR3 (CD11d, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin Exp Immunol 1993; 92: 181-4.
72. Bjerknes R, Odegaard S, Bjerkvig R, Borkje B, Laerum OD. Whipple's disease. Demonstration of a persisting monocyte and macrophage dysfunction. Scand J Gastroenterol 1988; 23: 611-9.
73. Marth T, Kleen N, Stallmach A, Ring S, Aziz, S, Schmidt C, et al. Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 2002; 123: 1468-77.
74. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM. Mice lacking IL12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL12 p40 subunit is present. J Immunol 2002; 168: 1322-7.
75. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance and favorable outcome of interleukin 12 receptor β1 deficiency: medical and immunological implications. J Exp Med 2003; 197: 527-35.
76. Lehmann J, Bellmann S, Werner C, Shroder R, Schutze N, Alber G. IL-12 p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J Immunol 2001; 167: 5304-15.
77. Frucht DM, Holland SM. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL12 regulation. J Immunol 1996; 157: 411-6.
78. Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997; 10: 611-36.
79. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini U, Gubler U, et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16: 495-521.
80. Wilcox CM, Rabebeck L, Friedman S. American Gastroenterological Association position statement: guidelines for the management of malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology 1996; 111: 1722-52.
81. Janoff E, Smith PD. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001; 120: 607-21.
82. Schneider T, Stallmach A, von Herbay A, Marth T, Strober W, Zeitz M. Treatment of refractory Whipple's disease with recombinant interferon-gamma. Ann Int Med 1998; 129: 875-7.
83. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med 1994; 330: 1348-55.
84. European study center on Whipple's disease. www.whipplesdisease.info.